NCT03984604

Investigation of the Efficacy and Safety of CHI-921 in Insomnia.

A Double-Blind, Randomized, Placebo-Controlled, Multi-Center Dose-Titration Study on the Efficacy and Safety of CHI-921 on Sleep Initiation and Maintenance in Subjects With Insomnia

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 21 (actual)
• Sponsor: Canopy Growth Corporation · Industry
• Sex: All
• Age: 25 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Insomnia is a disorder where people are having trouble sleeping and can include difficulty falling asleep, staying asleep and waking up too early, as well as having unrefreshing sleep. CHI-921 is a cannabis extract in sunflower oil produced as a treatment for insomnia. This trial is designed to evaluate the efficacy and safety of CHI-921 on people with insomnia.

Detailed description

The study is designed to: 1. Evaluate the patient-reported sleep latency and patient-reported wake after sleep onset after 3 weeks per treatment dose with CHI-921 compared to placebo. 2. To evaluate the effects of CHI-921 compared to placebo on PSG sleep architecture. 3. To evaluate the effects of CHI-921 compared to placebo on Patient Global Impression of change. 4. To evaluate the daytime residual effects that may be associated with CHI-921 as compared to placebo during the double-blind treatment period using patient's morning and evening questionnaire, Clinical Global Impression of change, Insomnia Severity Index, Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale as well as the Rey Auditory Verbal Learning Test and Digit Symbol Substitution psychometric tests. 5. To assess the effect on sleep of abruptly discontinuing CHI-921 compared to placebo (during run-out period). 6. To evaluate the clinical safety and tolerability of CHI-921 compared to placebo. 7. Evaluation of the accuracy of sleep data obtained by actigraphy as compared to traditional PSG.

Conditions

• Insomnia

Interventions

Type	Name	Description
DRUG	CHI-921	a standardized cannabis extract in sunflower oil administered in oral liquid (oil) form
DRUG	Placebo	Placebo is a vehicle oil will match CHI-921

Timeline

• Start date: 2019-03-21
• Primary completion: 2020-06-17
• Completion: 2020-06-17
• First posted: 2019-06-13
• Last updated: 2020-10-05

Locations

1 site across 1 country: Canada